Evidence map›Paper›PMID 39010888›Full record

ArticleERJ open research2024

Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVID.

Omer Elneima, John R Hurst, Carlos Echevarria, Jennifer K Quint, Samantha Walker, Salman Siddiqui, Petr Novotny, Paul E Pfeffer, Jeremy S Brown, Manu Shankar-Hari and 25 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Omer ElneimaThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0003-2480-8840
John R HurstUCL Respiratory, Department of Medicine, University College London, London, UK.ORCID https://orcid.org/0000-0002-7246-6040
Carlos EchevarriaNewcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
Jennifer K QuintSchool of Public Health, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-0149-4869
Samantha WalkerAsthma+Lung UK, London, UK.
Salman SiddiquiNational Heart and Lung Institute, Imperial College London, London, UK.
Petr NovotnyThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.
Paul E PfefferDepartment of Respiratory Medicine, Barts Health NHS Trust, London, UK.
Jeremy S BrownUCL Respiratory, Department of Medicine, University College London, London, UK.
Manu Shankar-HariCentre for Inflammation Research, University of Edinburgh, Edinburgh, UK.ORCID https://orcid.org/0000-0002-5338-2538
Hamish J C McAuleyThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0001-8997-0764
Olivia C LeavyThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.
Aarti ShikotraThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.
Amisha SingapuriThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.
Marco SerenoThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.
Matthew RichardsonThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.
Ruth M SaundersThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.
Victoria C HarrisThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.
Linzy Houchen-WolloffThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.
Neil J GreeningThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0003-0453-7529
Ewen M HarrisonCentre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.
Annemarie B DochertyCentre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.
Nazir I LoneCentre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.ORCID https://orcid.org/0000-0003-2707-2779
James D ChalmersUniversity of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
Ling-Pei HoMRC Translational Discovery Immunology Unit, University of Oxford, Oxford, UK.
Alex HorsleyDivision of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0003-1828-0058
Michael MarksDepartment of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.ORCID https://orcid.org/0000-0002-7585-4743
Krisnah PoinasamyAsthma+Lung UK, London, UK.
Betty RamanNIHR Oxford BRC, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID https://orcid.org/0000-0002-1239-9608
Rachael A EvansThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0002-1667-868X
Louise V WainThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0003-4951-1867
Aziz SheikhCentre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.
Chris E BrightlingThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre - Respiratory, University of Leicester, Leicester, UK.
Anthony De SoyzaNewcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.ORCID https://orcid.org/0000-0002-8566-0344
Liam G HeaneyWellcome-Wolfson Institute for Experimental Medicine, Queens University Belfast, Belfast, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Background: The long-term outcomes of COVID-19 hospitalisation in individuals with pre-existing airway diseases are unknown. Methods: Adult participants hospitalised for confirmed or clinically suspected COVID-19 and discharged between 5 March 2020 and 31 March 2021 were recruited to the Post-hospitalisation COVID-19 (PHOSP-COVID) study. Participants attended research visits at 5 months and 1 year post discharge. Clinical characteristics, perceived recovery, burden of symptoms and health-related quality of life (HRQoL) of individuals with pre-existing airway disease ( Results: A total of 615 out of 2697 (22.8%) participants had a history of pre-existing airway diseases (72.0% diagnosed with asthma, 22.9% COPD and 5.1% bronchiectasis). At 1 year, the airways group participants were less likely to feel fully recovered (20.4% Conclusion: Individuals with pre-existing airway diseases hospitalised due to COVID-19 were less likely to feel fully recovered, had lower physiological performance measurements, more burden of symptoms and reduced HRQoL up to 1 year post-hospital discharge.

Identifiers

PMID39010888
PMCPMC11247371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.